Overcome the Immunogenicity Limitations To Reach The Largest Population
Time: 2:00 pm
day: Track A - Day 1 PM
Details:
- Current limitations of gene transfer with AAV vectors
- Next generation vectors to overcome pre-existing humoral immunity to increase the reach of AAV gene therapy
- Next generation vectors and new methods to overcome post-treatment humoral immunity toward repeated vector administration
